BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/9/2018 7:24:30 AM | Browse: 1550 | Download: 2020
 |
Received |
|
2017-10-23 02:35 |
|
Peer-Review Started |
|
2017-10-25 03:22 |
|
To Make the First Decision |
|
2017-11-22 00:56 |
|
Return for Revision |
|
2017-11-27 07:54 |
|
Revised |
|
2017-12-31 16:52 |
|
Second Decision |
|
2018-01-15 08:31 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-01-15 20:40 |
|
Articles in Press |
|
2018-01-15 20:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-02-08 08:04 |
|
Publish the Manuscript Online |
|
2018-02-09 07:24 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Niels Steinebrunner, Kerstin Stein, Catharina Sandig, Thomas Bruckner, Wolfgang Stremmel and Anita Pathil |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anita Pathil, MD, Doctor, Doctor, Department of Internal Medicine IV, Gastroenterology and Hepatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany. anita.pathil-warth@med.uni-heidelberg.de |
| Key Words |
functional benefit; direct acting antiviral; hepatitis C; cirrhosis; real-life data |
| Core Tip |
Therapeutic regimens for patients with chronic hepatitis C virus (HCV) infection have substantially improved over the last few years. However real-life data in patients with cirrhosis are still limited, and predictors of functional benefit of direct-acting antivirals are not well defined. We analysed data from patients with HCV infection and liver cirrhosis to evaluate predictors of functional benefit for identifying patients profiting most from antiviral therapy beyond HCV eradication. |
| Publish Date |
2018-02-09 07:24 |
| Citation |
Steinebrunner N, Stein K, Sandig C, Bruckner T, Stremmel W, Pathil A. Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort. World J Gastroenterol 2018; 24(7): 852-861 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i7/852.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i7.852 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
